TAPINAROF CREAM IMPROVED ITCH IN TWO PHASE 3 TRIALS OF MODERATE TO SEVERE ATOPIC DERMATITIS

被引：0
作者：
Silverberg, J.
Boguniewicz, M.
Rubenstein, D.
Tallman, A.
Brown, P.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P282
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials
    Tofte, Susan J.
    Papp, Kim
    Sadick, Neil
    Bohnert, Krista
    Simpson, Eric
    Thaci, Diamant
    Bieber, Thomas
    Blauvelt, Andrew
    Sofen, Howard
    Gooderham, Melinda
    Chen, Zhen
    Gadkari, Abhijit
    Eckert, Laurent
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 (09): : 529 - 541
  • [42] Tapinarof cream in the treatment of atopic dermatitis in children and adults a systematic review and meta-analysis
    Ana Clara Felix de Farias Santos
    Fernanda Valeriano Zamora
    Deivyd Vieira Silva Cavalcante
    Beatriz Ximenes Mendes
    Gabriela Oliveira Gonçalves Molino
    Lorhayne Kerley Capuchinho Scalioni Galvao
    Nicole dos Santos Pimenta
    Belisa Brunow Ventura Biavatti
    João Pedro Costa Esteves Almuinha Salles
    Andres Villca Zamora
    Discover Medicine, 2 (1):
  • [43] Oral difelikefalin improves itch and inflammatory biomarkers in subjects with atopic dermatitis with moderate-to-severe pruritus
    Guttman-Yassky, Emma
    Facheris, Paola
    Da Rosa, Joel Correa
    Estrada, Yeriel
    David, Eden
    Pavel, Ana
    Bose, Swaroop
    Goncalves, Joana
    Nograles, Kristine
    Kim, Brian
    Lebwohl, Mark
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E116 - E116
  • [44] Dupilumab treatment induces rapid clinical improvement of itch in patients with moderate-to-severe atopic dermatitis
    Silverberg, Jonathan I.
    Eckert, Laurent
    Ardeleanu, Marius
    Chen, Zhen
    Akinlade, Bolanle
    Plaum, Stefan
    Graham, Neil M. H.
    Pirozi, Gianluca
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB113 - AB113
  • [45] Oral difelikefalin improves itch and inflammatory biomarkers in atopic dermatitis subjects with moderate-to-severe pruritus
    Guttman-Yassky, E.
    Facheris, P.
    Da Rosa, J. Correa
    Del Duca, E.
    Estrada, Y.
    David, E.
    Pavel, A.
    Bose, S.
    Goncalves, J.
    Nograles, K.
    Kim, B.
    Lebwohl, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S51 - S51
  • [46] Itch intensity in moderate-to-severe plaque psoriasis versus atopic dermatitis: A meta-analysis
    Shahwan, Kathryn T.
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : 1198 - +
  • [47] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
    Guttman-Yassky, Emma
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Weidinger, Stephan
    Hong, H. Chih-ho
    Hendrickson, Barbara
    Dilley, Deanne
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Irvine, Alan D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) : 172 - 181
  • [48] Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis
    Murase, Jenny E.
    Chovatiya, Raj
    Strowd, Lindsay
    Thyssen, Jacob P.
    Bangert, Christine
    Atwater, Amber Reck
    Gallo, Gaia
    Bardolet, Laia
    Yang, Fan
    Zhong, Jinglin
    Staumont-Salle, Delphine
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [49] Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream
    Blauvelt, A.
    Szepietowski, J. C.
    Papp, K.
    Simpson, E.
    Silverberg, J. I.
    Kim, B. S.
    Kwatra, S. G.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Kircik, L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S55 - S55
  • [50] Upadacitinib for moderate-to-severe atopic dermatitis: Stratified analysis from three randomized phase 3 trials by key baseline characteristics
    Thyssen, J. P.
    Thaci, D.
    Bieber, T.
    Gooderham, M.
    de Bruin-Weller, M.
    Soong, W.
    Kabashima, K.
    Barbarot, S.
    Luna, P. C.
    Xu, J.
    Hu, X.
    Liu, Y.
    Raymundo, E. M.
    Calimlim, B. M.
    Nduaka, C.
    Gamelli, A.
    Simpson, E. L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, : 1871 - 1880
12345